About this trial

This study aims to obtain the lacrimal fingerprint for frequent pathologies of the ocular surface and establish a normative base for each of them.

Eligibility criteria

Qualifiers

None

Disqualifiers

Patients younger than 18 years old;

Patients incapable of giving informed consent.

Trial design

Treatments tested in this trial

  • Tear sample collection via Schirmer strip and subsequent analysis by mass spectrometry

Treatment groups

300 Participants
are divided into 5 treatment groups

Locations

2
Centre Hospitalier de l'Université de Montréal (CHUM)H2X 3E4, MontrealQuebec, Canada
Université du Québec à Montréal (UQAM) - Department of ChemistryH2X 2J6, MontrealQuebec, Canada

Sponsors and collaborators

Centre hospitalier de l'Université de Montréal (CHUM)

Lead sponsor

Université du Québec a Montréal

Collaborator